Literature DB >> 17316380

WNT-conditioned media differentially affect the proliferation and differentiation of cord blood-derived CD133+ cells in vitro.

Teodora Nikolova1, Minyao Wu, Krassimir Brumbarov, Rüdiger Alt, Heike Opitz, Kenneth R Boheler, Michael Cross, Anna M Wobus.   

Abstract

Cord blood-derived CD133+ cells have a degree of non-hematopoietic potential and express transcripts of pluripotency markers including Oct-4, Sox-2, Rex-1, and leukemia inhibitory factor (LIF) receptor, as well as markers of progenitor cells, such as HoxB4, brachyury, and nestin. Having shown by transcriptome analysis that the mouse embryonic fibroblast (MEF) cells routinely used to maintain pluripotent embryonic stem cells express transcripts of the WNT/BMP families of signaling factors, we have assessed the effects on proliferation and differentiation of CD133+ cells of medium conditioned (CM) by MEF, by NIH3T3, and by NIH3T3 cells stably expressing WNT1, WNT3a, WNT4, WNT5a, and WNT11. Cultivation of CD133+ cells in MEF-CM led to a significant increase in cell number after 7 days of culture, while WNT-1, WNT3a-, and WNT11-CM increased the cell number significantly by 14 days of culture. During this period, WNT3a-CM increased the proportion of nestin-expressing cells and increased the ratio of blast-like cells to macrophages, suggesting that these signaling molecules contribute to the maintenance of an undifferentiated, blast-like phenotype. The number of cells expressing the endothelial-related marker CD31+ was significantly increased following culture in WNT5a- and WNT11-CM, whereas the number of cells positive for von Willebrand (vW) factor was maintained during 14 days of culture only in the presence of WNT4-CM. In addition, WNT5a-CM led to increased beta-catenin mRNA levels and the presence of beta-catenin protein in the cytoplasm and nucleus, consistent with the activation of the WNT signaling pathway. We conclude that in vitro conditioning of CD133+ cells by media containing specific WNT signaling factors influences the non-hematopoietic potential of CD133+ cells and dynamically alters the expression of the neural stem/progenitor cell marker nestin and the endothelial-related cell surface markers CD31 and vW factor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316380     DOI: 10.1111/j.1432-0436.2006.00119.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  12 in total

1.  NANOG induction of fetal liver kinase-1 (FLK1) transcription regulates endothelial cell proliferation and angiogenesis.

Authors:  Erin E Kohler; Colleen E Cowan; Ishita Chatterjee; Asrar B Malik; Kishore K Wary
Journal:  Blood       Date:  2010-11-30       Impact factor: 22.113

2.  Transduction of Wnt11 promotes mesenchymal stem cell transdifferentiation into cardiac phenotypes.

Authors:  Zhisong He; Hongxia Li; Shi Zuo; Zeeshan Pasha; Yigang Wang; Yueting Yang; Wenping Jiang; Muhammad Ashraf; Meifeng Xu
Journal:  Stem Cells Dev       Date:  2011-02-26       Impact factor: 3.272

3.  Mutations in Frizzled 6 cause isolated autosomal-recessive nail dysplasia.

Authors:  Anne-Sophie Fröjmark; Jens Schuster; Maria Sobol; Miriam Entesarian; Michaela B C Kilander; Dana Gabrikova; Sadia Nawaz; Shahid M Baig; Gunnar Schulte; Joakim Klar; Niklas Dahl
Journal:  Am J Hum Genet       Date:  2011-06-10       Impact factor: 11.025

Review 4.  Noncanonical Wnt11 signaling and cardiomyogenic differentiation.

Authors:  Michael P Flaherty; Buddhadeb Dawn
Journal:  Trends Cardiovasc Med       Date:  2008-10       Impact factor: 6.677

5.  CD133+ adult human retinal cells remain undifferentiated in Leukaemia Inhibitory Factor (LIF).

Authors:  Debra A Carter; Andrew D Dick; Eric J Mayer
Journal:  BMC Ophthalmol       Date:  2009-02-23       Impact factor: 2.209

Review 6.  Cancer stem cells: lessons from melanoma.

Authors:  Caterina La Porta
Journal:  Stem Cell Rev Rep       Date:  2008-12-18       Impact factor: 5.739

7.  Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2.

Authors:  Alessandra Giorgetti; Nuria Montserrat; Trond Aasen; Federico Gonzalez; Ignacio Rodríguez-Pizà; Rita Vassena; Angel Raya; Stéphanie Boué; Maria Jose Barrero; Begoña Aran Corbella; Marta Torrabadella; Anna Veiga; Juan Carlos Izpisua Belmonte
Journal:  Cell Stem Cell       Date:  2009-10-02       Impact factor: 24.633

8.  Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer.

Authors:  Anthony V Nguyen; Micaela Martinez; Michael J Stamos; Mary P Moyer; Kestutis Planutis; Christopher Hope; Randall F Holcombe
Journal:  Cancer Manag Res       Date:  2009-04-03       Impact factor: 3.989

9.  Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker.

Authors:  Meike Schneider; Johannes Huber; Boris Hadaschik; Gabrielle M Siegers; Heinz-Herbert Fiebig; Julia Schüler
Journal:  BMC Cancer       Date:  2012-03-20       Impact factor: 4.430

10.  Wnt1 Accelerates an Ex Vivo Expansion of Human Cord Blood CD34(+)CD38(-) Cells.

Authors:  Kamonnaree Chotinantakul; Patcharee Prasajak; Wilairat Leeanansaksiri
Journal:  Stem Cells Int       Date:  2013-08-20       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.